Shanghai Henlius Biotech
Clinical trials sponsored by Shanghai Henlius Biotech, explained in plain language.
-
Head-to-Head cancer drug battle: which treatment extends lives longer?
Disease control OngoingThis study compares two different immunotherapy drugs (serplulimab and atezolizumab) when combined with standard chemotherapy for people with advanced small cell lung cancer who haven't had previous treatment. Researchers want to see which drug combination helps patients live lon…
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Global trial aims to boost survival in aggressive lung cancer
Disease control OngoingThis large, late-stage study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy and radiation treatment helps people with limited-stage small cell lung cancer live longer without their cancer getting worse. It involves over 500 patients wo…
Phase: PHASE3 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC